CVS HEALTH Corp News
CVS Health Corporation provides health services in the United States. It operates through Health Care Benefits, Pharmacy Services, and Retail/LTC segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.
see moreCVS HEALTH Corp Market News
25 May at 04:24
CVS Stocks Slip After Legal, Insider Pressure Hits
- CVS Health posted stronger-than-expected Q1 results and raised 2026 adjusted EPS guidance, driven by Aetna cost controls and operational automation. Despite these fundamentals, recent legal headlines and insider sales pressured the stock, creating short-term volatility even as strategic initiatives like Health100 and prior-authorization automation support long-term resilience.
11 May at 04:24
CVS Rally: Q1 Beat, Aetna Margins Lift Guidance Up
CVS Health reported a stronger-than-expected Q1 with EPS and revenue beats, raised full-year guidance, and showed improved Aetna medical-loss ratios. Analysts upgraded targets, while PBM scrutiny, an FTC settlement and strike risks remain key watch items.
04 May at 04:24
CVS Rises on Medicare Advantage Gain, Vanguard Buy
CVS shares jumped after CMS raised Medicare Advantage rates and Vanguard increased its stake, strengthening confidence in Aetna’s outlook while spotlighting regulatory and PBM risks ahead of quarterly results.
27 Apr at 04:24
CVS Trims Stores, Boosts Stock With Pharmacy Focus
CVS Health launched smaller, pharmacy-only locations in metro Detroit this week while its stock outperformed the S&P 500 with a notable intraday rally. Rising short interest and a still-positive analyst target create a mixed investor picture; operational risks such as extreme weather remain on management’s radar.
20 Apr at 04:24
CVS Soars After CMS Raises Medicare Advantage Hike
CVS Health jumped after the Centers for Medicare & Medicaid Services (CMS) increased 2026 Medicare Advantage payment rates by 2.48%, a surprise boost that directly benefits Aetna and the company’s integrated PBM and retail operations. With Q1 2026 earnings set for May 6 and analysts raising price targets, investors are watching membership trends, insurance margins, and PBM dynamics. Recent volatility—an earlier March dip and a strong year-to-date gain—underscores policy sensitivity. This article breaks down the CMS decision’s mechanics, near-term catalysts for CVS stock in the S&P 500, and practical investor takeaways.
13 Apr at 04:24
CVS Stock Lifted by 2.48% Medicare Advantage Boost
A CMS decision to raise 2027 Medicare Advantage payment rates by 2.48%—adding roughly $13 billion to MA funding—provided a clear, short-term positive catalyst for CVS Health. The increase supports Aetna revenues, helped push shares higher alongside peers, and refocuses investor attention on managed-care margins, medical cost trends, and upcoming guidance.
06 Apr at 04:24
CVS Stock Reacts to Medicare Rate Shock, Guidance.
CVS shares swung this week after a CMS Medicare Advantage payment proposal and company earnings that mixed record revenue with a large goodwill impairment. Analyst support and dividend stability keep investor interest, but MA reimbursement, PBM scrutiny, and margin recovery remain the primary near-term catalysts.